Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

2594557 Title: Dérivés aminopropioniques substitués en tant qu'inhibiteurs de néprilysine

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
131517955
WO application number:
Type:
European patent granted for BE
Status:
Deemed Void
Publication number:
2594557
WO publication number:
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
26/05/2010
Grant date:
10/08/2016
EP publication date:
22/05/2013
WO publication date:
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
10/08/2016
EP B1 publication date:
10/08/2016
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
26/05/2030

Applicant

Name:
Novartis AG
Legal Form:
From:
10/08/2016
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)
To:

Inventor

1

Name:
Coppola, Gary Mark
Legal Form:
Address:
Budd Lake, NJ 07828, United States (US)

2

Name:
Iwaki, Yuki
Legal Form:
Address:
Cambridge, MA 02139, United States (US)

3

Name:
Karki, Rajeshri Ganesh
Legal Form:
Address:
Cambridge, MA 02139, United States (US)

4

Name:
Kawanami, Toshio
Legal Form:
Address:
Cambridge, MA 02139, United States (US)

5

Name:
Ksander, Gary Michael
Legal Form:
Address:
Cambridge, MA 02139, United States (US)

6

Name:
Mogi, Muneto
Legal Form:
Address:
Cambridge, MA 02139, United States (US)

7

Name:
Sun, Robert
Legal Form:
Address:
Cambridge, MA 02139, United States (US)

Priority

1

Priority patent number:
181756 P
Priority date:
28/05/2009
Priority country:
United States (US)

2

Priority patent number:
263145 P
Priority date:
20/11/2009
Priority country:
United States (US)

3

Priority patent number:
324943 P
Priority date:
16/04/2010
Priority country:
United States (US)

Classification

IPC or IDT classification:
C07D 213/82; C07D 239/36; C07D 261/18; C07D 271/06; C07C 233/47; A61K 31/21; A61K 31/435;

Publication

European Patent Bulletin

Issue number:
201632
Publication date:
10/08/2016
Description:
Grant (B1)

Annual fee

Annual fee(s) Due Date:
31/05/2017
Annual fee number:
8
Annual fee amount:
135 Euro
Expected payer:
Last annual fee payment date:
Last annual fee paid number:
Payer:
Filing date Document type Publication Type Document Description Number of pages File Type